Nurix Therapeutics (NRIX) FCF Margin Growth (1y) (2020 - 2026)
Nurix Therapeutics (NRIX) FCF Margin Growth (1y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1,187.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1,525.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -341.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Nurix Therapeutics | 2.64 Bn | 2.19 Bn | - | -94,417.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | -94,417.00 |
| Feb 28, 2026 | -82,754.00 |
| Nov 30, 2025 | -16,731.00 |
| Aug 31, 2025 | -36,344.00 |
| May 31, 2025 | 19,935.00 |
| Feb 28, 2025 | -9,183.00 |
| Nov 30, 2024 | -53,566.00 |
| Aug 31, 2024 | -14,060.00 |
| May 31, 2024 | -27,354.00 |
| Feb 29, 2024 | 14,181.00 |
| Nov 30, 2023 | 80,763.00 |
| Aug 31, 2023 | 25,782.00 |
| May 31, 2023 | 21,737.00 |
| Feb 28, 2023 | 7,927.00 |
| Nov 30, 2022 | -16,778.00 |
| Aug 31, 2022 | -16,063.00 |
| May 31, 2022 | 16,029.00 |
| Feb 28, 2022 | -62,306.00 |
| Nov 30, 2021 | -10,985.00 |
| Aug 31, 2021 | -14,203.00 |